# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001562762-23-000118
Filing Date
2023-03-16
Accepted
2023-03-16 17:29:50
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-03-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | Cassava_ARS_2022.pdf | ARS | 1933731
| Complete submission text file | 0001562762-23-000118.txt |  | 2663779

Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-29959 | Film No.: 23739935
SIC: 2834 Pharmaceutical Preparations